FMA
CCXI

FNY Managed Accounts’s ChemoCentryx, Inc. CCXI Stock Holding History

FNY Managed Accounts’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$2K Buy
+205
New +$2.12K ﹤0.01% 455

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FNY Managed Accounts's CCXI Position: Q1 2018 in Review

FNY Managed Accounts opened a new position in ChemoCentryx, Inc. (CCXI) in Q1 2018: 205 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #455 among its holdings.

100 funds tracked by Wall St. Rank hold CCXI as of Q1 2018.

  • FNY Managed Accounts held 205 shares of ChemoCentryx, Inc. worth $2K as of Q1 2018.
  • ChemoCentryx, Inc. was a new FNY Managed Accounts position in Q1 2018.
  • ChemoCentryx, Inc. made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #455 holding.
  • 100 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.